NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
2021-08-12 $182.50 $182.50 $182.50 $182.50 0
2021-08-11 $182.50 $182.50 $182.50 $182.50 0
2021-08-10 $182.50 $182.50 $182.50 $182.50 0
2021-08-09 $182.50 $182.50 $182.50 $182.50 0
2021-08-06 $182.50 $182.50 $182.50 $182.50 0
2021-08-05 $182.50 $182.50 $182.50 $182.50 0
2021-08-04 $182.50 $182.50 $182.50 $182.50 0
2021-08-03 $182.50 $182.50 $182.50 $182.50 0
2021-08-02 $182.50 $182.50 $182.50 $182.50 0
2021-07-30 $182.50 $182.50 $182.50 $182.50 0
2021-07-29 $182.50 $182.50 $182.50 $182.50 0
2021-07-28 $182.50 $182.50 $182.50 $182.50 10
2021-07-27 $182.50 $182.50 $182.50 $182.50 335 499
2021-07-26 $182.50 $182.50 $182.50 $182.50 0
2021-07-23 $182.50 $182.50 $182.50 $182.50 0
2021-07-22 $182.50 $182.50 $182.50 $182.50 0
2021-07-21 $182.50 $182.50 $182.50 $182.50 3
2021-07-20 $181.04 $182.67 $180.13 $182.50 90 506 123
2021-07-19 $179.25 $180.37 $178.51 $179.45 10 068 088
2021-07-16 $180.10 $181.52 $179.27 $180.03 10 300 623
2021-07-15 $184.48 $184.72 $180.21 $180.51 8 410 329
2021-07-14 $187.26 $187.45 $186.25 $186.61 8 296 251
2021-07-13 $185.14 $186.46 $185.14 $185.98 1 370 749
2021-07-12 $185.26 $186.80 $185.15 $185.91 2 976 671
2021-07-09 $183.24 $185.50 $182.64 $184.20 10 846 830
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT